2seventy bio Inc (TSVT)
4.76
-0.17
(-3.45%)
USD |
NASDAQ |
May 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Revenue (Quarterly): 10.68M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.68M |
| September 30, 2023 | 12.03M |
| June 30, 2023 | 36.05M |
| March 31, 2023 | 41.62M |
| December 31, 2022 | 56.18M |
| September 30, 2022 | 13.41M |
| June 30, 2022 | 13.48M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.429M |
| December 31, 2021 | 16.03M |
| September 30, 2021 | 19.26M |
| June 30, 2021 | 7.328M |
| March 31, 2021 | 11.90M |
| December 31, 2020 | 9.905M |
| September 30, 2020 | 18.43M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.328M
Minimum
Jun 2021
56.18M
Maximum
Dec 2022
19.62M
Average
13.44M
Median
Revenue (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 11.86B |
| Johnson & Johnson | 21.38B |
| Macrogenics Inc | 9.164M |
| Akebia Therapeutics Inc | 56.20M |
| Tango Therapeutics Inc | 5.431M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.82M |
| Total Expenses (Quarterly) | 70.56M |
| EPS Diluted (Quarterly) | -1.11 |
| Enterprise Value | 27.25M |
| Gross Profit Margin (Quarterly) | 70.54% |
| Profit Margin (Quarterly) | -531.8% |
| Earnings Yield | -92.86% |
| Normalized Earnings Yield | -84.27 |